Gi Dynamics Inc Quick Ratio (GIDYL) starting from the first quarter 2021 to first quarter 2020, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Gi Dynamics Inc   (GIDYL)

Gi Dynamics Inc 's Quick Ratio

GIDYL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2021, Quick Ratio deteriorated to 0.82 below Gi Dynamics Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 178 other companies have achieved higher Quick Ratio than Gi Dynamics Inc in first quarter 2021. While Quick Ratio total ranking in the first quarter 2021 has deteriorated compared to the prior quarter from 2238 to 3184.

Explain Quick Ratio?
How much Cash & cash equivalents GIDYL´s has?
What are GIDYL´s Current Liabilities?




GIDYL Quick Ratio (Mar 31 2021)
Q1
(Dec 31 2020)
Q4
(Sep 30 2020)
Q3
(Jun 30 2020)
Q2
(Mar 31 2020)
Q1
Y / Y Current Liabilities Change -82.25 % -84.99 % -76.56 % 21.24 % -12.51 %
Y / Y Cash & cash equivalent Change -75.84 % -53.62 % 90.66 % -69.8 % 199.69 %
Quick Ratio MRQ 0.82 0.91 1.7 0.09 0.6
GIDYL's Total Ranking # 3184 # 2238 # 1326 # 4261 # 2648
Seq. Current Liabilities Change -10.89 % -19.14 % -80.94 % 29.25 % -24.61 %
Seq. Cash & cash equivalent Change -19.67 % -56.67 % 264.94 % -80.98 % 54.22 %



Quick Ratio first quarter 2021 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 179
Healthcare Sector # 980
Overall Market # 3184


Quick Ratio Statistics
High Average Low
8.71 2.96 0.09
(Jun 30 2014)   (Jun 30 2020)




Financial Statements
Gi Dynamics Inc 's Current Liabilities $ 1 Millions Visit GIDYL's Balance sheet
Gi Dynamics Inc 's Cash & cash equivalent $ 1 Millions Visit GIDYL's Balance sheet
Source of GIDYL's Sales Visit GIDYL's Sales by Geography


Cumulative Gi Dynamics Inc 's Quick Ratio

GIDYL's Quick Ratio for the trailling 12 Months

GIDYL Quick Ratio

(Mar 31 2021)
12 Months
(Dec 31 2020)
12 Months
(Sep 30 2020)
12 Months
(Jun 30 2020)
12 Months
(Mar 31 2020)
12 Months
Y / Y Current Liabilities TTM Growth -56.89 % -40.3 % -13.38 % 2.78 % -2.06 %
Y / Y Cash & cash equivalent TTM Growth -46.01 % 10.58 % 9.4 % -20.09 % -6.2 %
Quick Ratio TTM 0.45 0.48 0.39 0.28 0.36
Total Ranking TTM # 4765 # 2641 # 4763 # 2758 # 4770
Seq. Current Liabilities TTM Growth -30.04 % -29.17 % -17.23 % 5.1 % -3.12 %
Seq. Cash & cash equivalent TTM Growth -34.71 % -13.73 % 14.98 % -16.64 % 33.72 %


On the trailing twelve months basis In spite of the year on year decrease in GIDYL's Current Liabilities to $1.14 millions, cumulative Quick Ratio to 0.45 below the GIDYL average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 198 other companies have achieved higher Quick Ratio than Gi Dynamics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2020 from 2641 to 4765.

Explain Quick Ratio?
How much Cash & cash equivalents GIDYL´s has?
What are GIDYL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 199
Healthcare Sector # 942
Within the Market # 4765


trailing twelve months Quick Ratio Statistics
High Average Low
5.58 1.88 0.27
(Jun 30 2016)   (Dec 31 2019)




Companies with similar Quick Ratio in the quarter ending Mar 31 2021, within Medical Equipment & Supplies Industry Quick RatioMar 31 2021 MRQ Cash & cash equivalentMar 31 2021 MRQ Current Liabilities
Seaspine Holdings Corporation  2.20 $ 87.749  Millions$ 39.928  Millions
Penumbra Inc  2.17 $ 242.609  Millions$ 111.862  Millions
Logicmark Inc  2.09 $ 8.516  Millions$ 4.068  Millions
Orthopediatrics Corp  2.09 $ 76.635  Millions$ 36.623  Millions
Universal Biosensors Inc   2.07 $ 15.766  Millions$ 7.618  Millions
Anika Therapeutics Inc   2.01 $ 94.599  Millions$ 46.973  Millions
Marizyme Inc   1.94 $ 0.865  Millions$ 0.445  Millions
Pear Therapeutics Inc   1.89 $ 0.749  Millions$ 0.397  Millions
Brainsway Ltd   1.87 $ 16.921  Millions$ 9.067  Millions
Globus Medical Inc   1.77 $ 218.711  Millions$ 123.677  Millions
Plus Therapeutics Inc   1.76 $ 14.447  Millions$ 8.202  Millions
Nu med Plus Inc   1.64 $ 0.139  Millions$ 0.085  Millions
Intersect Ent Inc   1.62 $ 70.524  Millions$ 43.538  Millions
Mimedx Group Inc   1.53 $ 84.746  Millions$ 55.411  Millions
Ufp Technologies Inc   1.52 $ 25.377  Millions$ 16.668  Millions
Sharecare Inc   1.44 $ 0.325  Millions$ 0.226  Millions
Genedx Holdings Corp   1.39 $ 58.652  Millions$ 42.102  Millions
Edwards Lifesciences Corporation  1.35 $ 1,330.600  Millions$ 987.800  Millions
Nexgel Inc   1.33 $ 1.070  Millions$ 0.803  Millions
Steris Plc  1.31 $ 220.531  Millions$ 168.651  Millions
National Vision Holdings Inc   1.26 $ 453.792  Millions$ 359.828  Millions
Dexcom Inc   1.26 $ 733.800  Millions$ 584.000  Millions
Encision Inc   1.25 $ 1.474  Millions$ 1.176  Millions
Yubo International Biotech Limited  1.25 $ 0.304  Millions$ 0.244  Millions
Glaukos Corp  1.21 $ 407.380  Millions$ 335.564  Millions
Sonoma Pharmaceuticals Inc   1.21 $ 4.220  Millions$ 3.482  Millions
Pro dex Inc   1.21 $ 4.997  Millions$ 4.142  Millions
Surgalign Holdings Inc   1.14 $ 63.763  Millions$ 56.017  Millions
Align Technology inc   1.13 $ 1,131.698  Millions$ 1,000.905  Millions
Medtronic Plc  1.11 $ 10,817.000  Millions$ 9,742.000  Millions

Date modified: 2026-09-08T15:10:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.